Peptides and IVF: Kisspeptin, NAD+, and What the Fertility Research Actually Shows
If you’re going through IVF or preparing for a fertility treatment cycle, you’re probably researching everything that could improve your chances. Peptides like kisspeptin, BPC-157, and NAD+ have mechanisms that theoretically relate to reproductive function — but the evidence for using them alongside IVF is almost entirely preclinical. Here’s what the research actually shows and what it doesn’t.
Kisspeptin: The Fertility Peptide Under Active Investigation
Kisspeptin-10 is the most directly fertility-relevant peptide. It is the master regulator of the HPG axis — the hormonal cascade that controls ovulation. Kisspeptin triggers GnRH release from the hypothalamus, which triggers LH and FSH from the pituitary, which drives follicle development and ovulation.
Clinical research is actively exploring kisspeptin as a trigger for final oocyte maturation in IVF, potentially as an alternative to hCG triggers. Published human studies at Imperial College London have shown that kisspeptin-54 can trigger egg maturation with a lower risk of ovarian hyperstimulation syndrome (OHSS) compared to hCG. This is particularly relevant for women with PCOS, who are at higher OHSS risk.
⚠ Critical Distinction: The kisspeptin-10 available from research peptide suppliers is NOT the same formulation used in clinical IVF trials. Clinical trials use pharmaceutical-grade kisspeptin under controlled conditions with precise timing. Do not attempt to self-administer kisspeptin as an IVF trigger without explicit guidance from your reproductive endocrinologist.
Other Peptides With Theoretical Fertility Relevance
NAD+ — Egg Quality
Oocyte quality declines with age partly due to mitochondrial dysfunction. NAD+ supports mitochondrial function, and animal studies have shown that NAD+ precursors (NMN) can improve oocyte quality in aged mice. Human data is limited but the biological rationale is sound. NAD+ supplementation is being explored in the fertility space, though primarily through oral precursors (NMN/NR) rather than injectable NAD+.
GHK-Cu — Endometrial Receptivity (Theoretical)
GHK-Cu promotes tissue remodeling and blood vessel formation. Endometrial receptivity depends on proper vascularization and tissue development. The connection is theoretical — no studies have directly tested GHK-Cu for endometrial preparation.
What to Discuss With Your RE
If you’re considering peptides alongside IVF:
- Disclose everything to your reproductive endocrinologist. Peptides can affect hormonal signaling.
- Timing matters: Some peptides should be discontinued before an IVF cycle to avoid interference with controlled stimulation protocols.
- Focus on proven interventions first: CoQ10, DHEA (if indicated), vitamin D, folate, and lifestyle optimization have more clinical support than research peptides for fertility.
BioPure Peptides
Code: POWERKisspeptin-10, NAD+, GHK-Cu. Research-grade with third-party testing.
Shop Kisspeptin-10 →Shop NAD+ →Frequently Asked Questions
Related Articles
Find Your Peptide Match
Take our 60-second quiz for personalized peptide recommendations based on your goals and life stage.
Take the Quiz →